R
Ravindra Sarode
Researcher at University of Texas Southwestern Medical Center
Publications - 154
Citations - 7345
Ravindra Sarode is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Thrombotic thrombocytopenic purpura & Medicine. The author has an hindex of 37, co-authored 139 publications receiving 6792 citations. Previous affiliations of Ravindra Sarode include University of Texas at Austin & Post Graduate Institute of Medical Education and Research.
Papers
More filters
Journal ArticleDOI
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
Gallia Levy,William C. Nichols,Eric C.-Y. Lian,Tatiana Foroud,Jeanette N. McClintick,Beth McGee,Angela Y. Yang,David R. Siemieniak,Kenneth R. Stark,Ralph A. Gruppo,Ravindra Sarode,Susan B. Shurin,Visalam Chandrasekaran,Sally P. Stabler,Hernan Sabio,Eric E. Bouhassira,Jefferson D. Upshaw,David Ginsburg,Han-Mou Tsai +18 more
TL;DR: In this article, the ADAMTS family of zinc metalloproteinase genes (ADAMTS13) was identified as the molecular mechanism responsible for TTP, and it was shown that the deficiency of ADADTS13 is the molecular mechanisms responsible for the development of TTP.
Journal ArticleDOI
Thrombotic thrombocytopenic purpura associated with clopidogrel.
Charles L. Bennett,Jean M. Connors,John M. Carwile,Joel L. Moake,William R. Bell,Stefano R. Tarantolo,Leo J. McCarthy,Ravindra Sarode,Amy J. Hatfield,Marc D. Feldman,Charles J. Davidson,Han-Mou Tsai,Elizabeth L. Michalets +12 more
TL;DR: Thrombotic thrombocytopenic purpura can occur after the initiation of clopidogrel therapy, often within the first two weeks of treatment, and Physicians should be aware of the possibility of this syndrome when initiating clopIDogrel treatment.
Journal ArticleDOI
Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.
Zbigniew M. Szczepiorkowski,Jeffrey L. Winters,Nicholas Bandarenko,Haewon C. Kim,Michael L. Linenberger,Marisa B. Marques,Ravindra Sarode,Joseph E. Schwartz,Robert Weinstein,Beth H. Shaz +9 more
TL;DR: The Fourth ASFA Special Issue is significantly modified in comparison to the previous editions and a new concept of a fact sheet has been introduced that succinctly summarizes the evidence for the use of therapeutic apheresis.
Journal ArticleDOI
Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial
Joshua N. Goldstein,Majed A. Refaai,Truman J. Milling,Brandon Lewis,Robert Goldberg-Alberts,Bruce A. Hug,Ravindra Sarode +6 more
TL;DR: 4F-PCC is non-inferior and superior to plasma for rapid INR reversal and effective haemostasis in patients needing VKA reversal for urgent surgical or invasive procedures.
Journal ArticleDOI
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways
Gordon F. Tomaselli,Kenneth W. Mahaffey,Adam Cuker,Paul P. Dobesh,John U. Doherty,John W. Eikelboom,Roberta Florido,William J. Hucker,Roxana Mehran,Steven R. Messé,Charles V. Pollack,Fatima Rodriguez,Ravindra Sarode,Deborah M. Siegal,Barbara S. Wiggins +14 more
TL;DR: This work was supported by a grant from the National Institutes of Health (NIH) and a collection of donations made by the public and private sectors.